PhonePe revenue up 85%, losses down 44% in FY21

PhonePe, a digital payments platform backed by US-based retailer Walmart Inc and homegrown ecommerce entity Flipkart, has reported revenue from operations of Rs 690 crore in the previous financial year, a jump of 85%, according to its latest regulatory documents sourced by ET.

PhonePe, which competes with Paytm, Google Pay and Amazon Pay, has reported marginally lower net loss of Rs 1,727 crore for the period.

Excluding a
one-time allocation for employee stock options, the loss is around Rs 884 crore, down around 44%.

The narrowed losses is an outcome of PhonePe cutting operational costs. It has significantly reduced its marketing and promotional spends, by around 47%, to about Rs 535 crore from Rs 1,016 crore in FY20.

Its revenue has increased as it continues to expand outside payments to build a financial services business that has started generating revenue for the company.

Last month, cofounder and chief executive Sameer Nigam told ET that the company
may apply for an Asset Management Company (AMC) licence, which will allow it to sell its own mutual funds.

STARTUP ROCKSTARS IN 2021

Sign-in to see our list of the most promising startups of 2021



PhonePe already sells mutual funds of other companies on its platform, besides insurance policies.

The company is the leader on the Unified Payments Interface (UPI) as well as the Bharat Bill Payment Systems.

For all the latest Technology News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.